Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 29.68M | 20.70M | 27.68M | 22.12M | 19.52M | 11.45M |
Gross Profit | 1.23M | -985.08K | 2.46M | 1.26M | 1.99M | 1.07M |
EBITDA | 875.18K | -1.85M | -9.19M | -9.25M | -5.32M | -6.55M |
Net Income | -709.76K | -4.54M | -13.43M | -10.83M | -6.34M | -7.05M |
Balance Sheet | ||||||
Total Assets | 10.21M | 6.03M | 6.92M | 11.37M | 20.96M | 6.77M |
Cash, Cash Equivalents and Short-Term Investments | 862.79K | 357.60K | 195.04K | 5.86M | 11.87M | 4.13M |
Total Debt | 12.68M | 12.52M | 12.21M | 8.98M | 8.44M | 4.15M |
Total Liabilities | 21.95M | 19.95M | 22.45M | 14.53M | 14.27M | 7.01M |
Stockholders Equity | -11.74M | -13.91M | -15.54M | -3.16M | 6.69M | -237.91K |
Cash Flow | ||||||
Free Cash Flow | -4.02M | -3.00M | -3.91M | -5.84M | -5.92M | -1.99M |
Operating Cash Flow | -4.02M | -3.00M | -3.89M | -5.72M | -5.92M | -1.99M |
Investing Cash Flow | -40.46K | -40.18K | -318.38K | -928.58K | -357.41K | 0.00 |
Financing Cash Flow | 4.72M | 3.17M | -1.39M | -312.04K | 13.99M | 6.22M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
63 Neutral | C$59.24M | 13.32 | 57.30% | ― | 10.57% | ― | |
54 Neutral | C$4.43B | 4.00 | -20.57% | 3.83% | 8.18% | 1.50% | |
37 Underperform | C$9.40M | ― | 162.13% | ― | -5.97% | 63.24% | |
30 Underperform | C$671.06K | 0.64 | -229.06% | ― | ― | ― | |
27 Underperform | C$4.39M | ― | -78.70% | ― | -97.30% | 39.70% |
Organto Foods Inc. has successfully closed a non-brokered private placement, raising C$1.0 million through the issuance of 4,000,000 units at a price of $0.25 per unit. This financing was completed with a strategic investor and will support the company’s general working capital. The transaction includes common shares and warrants, with a hold period until October 27, 2025. This move is expected to bolster Organto’s operational capabilities and enhance its market positioning in the organic produce industry.
Organto Foods Inc. announced the results of its annual general meeting, where 57.9% of eligible shares were voted, and all matters received over 99% support. Shareholders elected five directors and approved the appointment of Dale Matheson Carr-Hilton Labonte LLP as the independent auditor for the next year. The continuation of the company’s Share Option and Restricted Share Unit Plans was also approved, indicating strong shareholder confidence in Organto’s strategic direction.
Organto Foods Inc. has announced the final settlement of its convertible debenture obligations, exchanging C$8,050,000 worth of debentures for 40,250,000 common shares. This move is part of Organto’s strategy to reduce debt and increase equity, positioning the company for future growth. The settlement reflects the company’s commitment to building a world-class foods company and creating long-term value for stakeholders. The company has also engaged Jaluca Limited to assist in its restructuring efforts, issuing additional shares as part of the advisory agreement.
Organto Foods Inc. announced a C$1.0 million private placement financing with a strategic investor, aiming to issue up to 4,000,000 units at $0.25 per unit. This move is part of Organto’s strategy to manage its balance sheet conservatively while capitalizing on its recent operational success, including significant sales and profit growth. The proceeds will be used for general working capital, and the transaction is subject to regulatory approvals. The announcement reflects the company’s ongoing restructuring efforts and strategic realignment, which have laid a foundation for sustained growth and profitability.
Organto Foods Inc. announced record-breaking financial results for the first quarter of 2025, with sales reaching $13.6 million, a 193.5% increase from the previous year. The company achieved its first positive EBITDA quarter, attributed to strategic restructuring and cost reduction efforts. This performance highlights Organto’s momentum towards sustained growth and profitability, as well as its commitment to creating lasting value for stakeholders.
Organto Foods Inc. announced that its debentureholders have approved the settlement terms for its 5-year, 8% convertible unsecured subordinated debentures. The resolution allows for the conversion of $8,050,000 worth of debentures into 40,250,000 common shares, effectively reducing the company’s debt and increasing equity. This move is part of Organto’s ongoing efforts to improve its financial structure and enhance its market position. The approval by debentureholders representing 68.89% of the outstanding principal amount eliminates the need for a formal meeting, although the settlement still requires approval from the TSX Venture Exchange.
Organto Foods Inc. reported its fiscal 2024 financial results, highlighting a significant restructuring and realignment that has positioned the company for sustained growth and profitability. The company achieved a 48% increase in sales to $20.7 million, driven by onboarding new business and expanding sales with existing customers. Despite a net loss from continuing operations of $3.3 million, Organto reduced its net loss including discontinued operations to $2.0 million, down from $13.4 million in 2023, aided by gains from the sale of subsidiaries and improved operating earnings. The company remains focused on positive cash flow and is optimistic about its future prospects.
Organto Foods Inc. has announced new investor relations agreements and the issuance of stock options to its directors, officers, and employees. The company has engaged 12538938 Canada Inc. for strategic communication services and Atrium Research Corporation for issuer-paid research to enhance its investment case to potential investors. These initiatives aim to strengthen Organto’s market presence and investor engagement, potentially impacting its operational strategies and stakeholder relations.
Organto Foods Inc. has successfully closed a private placement, raising C$5,309,991 through the issuance of common shares, and has settled outstanding debts amounting to C$2,243,300 via a shares-for-debt arrangement. Additionally, the company has amended the terms of its convertible notes, reducing the conversion and acceleration prices, and extending the maturity dates, which could enhance its financial flexibility and improve its market positioning.